Silver sulfadiazine for control of burn wound infections.
Silver sulfadiazine (Silvadene, U.S.; Flamazine, U.K.; Flammazine, N.; Sulplata, S.A.) is the newest topical antimicrobial agent available following worldwide clinical trials. Good control of infection is achieved without pain or other demonstrable side effects, using either dressings or the exposure technic. Many burned areas kept free of infection heal without grafting. Where necessary, early preparation for and good take of grafts has been attained by utilizing this new therapeutic agent. Markedly reduced mortality from burn wound sepsis has generally been observed.
D000328:Adult; D000368:Aged; D001458:Bandages; D002056:Burns / Q000150:complications*; D002648:Child; D006801:Humans; D008875:Middle Aged; D009824:Ointments; D012834:Silver / Q000009:adverse effects / Q000627:therapeutic use*; D016038:Skin Transplantation; D013411:Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013709:Tendon Transfer; D014182:Transplantation, Autologous; D014946:Wound Infection / Q000517:prevention & control*
D009824:Ointments; D013411:Sulfadiazine; D012834:Silver